Harvard Bioscience, Inc.NASDAQ: HBIO

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8: 00 AM ET

· Issued by Harvard Bioscience, Inc. via GlobeNewswire

Summary by 6ix AI

Harvard Bioscience, Inc., which makes life science research tools, products and services, will release its results for the quarter ended June 30, 2026 before the market opens on August 11, 2026, and will hold a conference call to discuss them at 8:00 a.m. Eastern Time.

Key details

  • Analysts who want to ask questions on the call must register to receive dial-in numbers and a unique PIN; others can listen through an audio-only webcast on the company's investor website.
  • The earnings release and a related slide presentation will be posted in the Investor Relations section of Harvard Bioscience's website.

6ix AI wrote this summary from the release below and checked it against the release.

HOLLISTON, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2026, before the market opens on August 11, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.

Analysts who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.

Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience's website.

About Harvard Bioscience

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world's leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Company Contact:
Mark Frost
Chief Financial Officer
(508) 893-3120
[email protected]

Harvard Bioscience, Inc. on 6ix

Story so far

Earlier from Harvard Bioscience

Later from Harvard Bioscience

All Harvard Bioscience news releases